Wilfried Grossmann

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Lisa Maria Neuhofer

> Home > Persons > Wilfried Grossmann

Publications

2015
[c23]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - conf/mie/SauterRNEGWEG15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/mie/SauterRNEGWEG15
Simone Katja Sauter, Christoph Rinner, Lisa Maria Neuhofer, Doron Edlinger, Wilfried Grossmann, Michael Wolzt, Gottfried Endel, Walter Gall:
Secondary use of Austrian health claims data to explore adverse drug events. MIE 2015: 946
2014
[c20]
- view
  authority control:
- export record
  dblp key:
  - conf/ehealth2/RinnerSNEGWEG14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/ehealth2/RinnerSNEGWEG14
Christoph Rinner, Simone Katja Sauter, Lisa Maria Neuhofer, Doron Edlinger, Wilfried Grossmann, Michael Wolzt, Gottfried Endel, Walter Gall:
Estimating Severe Drug-Drug Interaction Warnings per Medical Specialist Groups for Nationwide eMedication in Austria. eHealth 2014: 246
[c19]
- view
  authority control:
- export record
  dblp key:
  - conf/ehealth2/EdlingerSRNWGEG14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/ehealth2/EdlingerSRNWGEG14
Doron Edlinger, Simone Katja Sauter, Christoph Rinner, Lisa Maria Neuhofer, Michael Wolzt, Wilfried Grossmann, Gottfried Endel, Walter Gall:
JADE: A Tool for Medical Researchers to Explore Adverse Drug Events Using Health Claims Data. eHealth 2014: 249

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.